A Research Study to See How Safe is Eptacog Alfa When Used to Stop Heavy Bleeding in Women After Giving Birth in India
Clinical trial NCT07157423 · RECRUITING
Trial details
- NCT number
- NCT07157423
- Sponsor
- Novo Nordisk A/S
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-26
- Primary completion
- 2027-08-26
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.